发明名称 Method for diagnosing efficacy of xenotypic antibody therapy
摘要 <p>The invention provides methods for diagnosing the efficacy of a patient to xenotypic antibody therapy which include (1) measuring the level of an antibody produced by a patient that specifically binds to a xenotypic antibody after administration of the xenotypic antibody to the patient; (2) measuring the level of an anti-idiotype antibody produced by a patient that specifically binds to a xenotypic antibody after administration of the xenotypic antibody to the patient; (3) measuring the level of an antibody produced by a patient that specifically binds to a target antigen of a xenotypic antibody after administration af a xenotypic antibody to the patient; and (4) measuring the level of a T cell response produced by a patient to a target antigen of the xenotypic antibody after administration of a xenotypic antibody to the patient. In the methods of the invention, an increase in the level of antibody or T cell response produced by the patient after the administration of the xenotypic antibody relative to the level antibody or T cell response produced by the patient prior to the administration of the xenotypic antibody is indicative of a favorable diagnosis of efficacy.</p>
申请公布号 EP1821104(A2) 申请公布日期 2007.08.22
申请号 EP20070007737 申请日期 2001.02.08
申请人 ALTAREX MEDICAL CORPORATION 发明人 NOUJAIM, ANTOINE
分类号 G01N33/53;G01N33/68;A61K49/00;G01N33/569;G01N33/574 主分类号 G01N33/53
代理机构 代理人
主权项
地址